全文获取类型
收费全文 | 1324587篇 |
免费 | 101929篇 |
国内免费 | 4219篇 |
专业分类
耳鼻咽喉 | 16780篇 |
儿科学 | 43454篇 |
妇产科学 | 36350篇 |
基础医学 | 196174篇 |
口腔科学 | 35870篇 |
临床医学 | 128796篇 |
内科学 | 255482篇 |
皮肤病学 | 26347篇 |
神经病学 | 110958篇 |
特种医学 | 48108篇 |
外国民族医学 | 366篇 |
外科学 | 183448篇 |
综合类 | 28734篇 |
现状与发展 | 1篇 |
一般理论 | 460篇 |
预防医学 | 113289篇 |
眼科学 | 28907篇 |
药学 | 98534篇 |
6篇 | |
中国医学 | 3096篇 |
肿瘤学 | 75575篇 |
出版年
2019年 | 11623篇 |
2018年 | 16299篇 |
2017年 | 12281篇 |
2016年 | 13242篇 |
2015年 | 15190篇 |
2014年 | 20792篇 |
2013年 | 32043篇 |
2012年 | 44226篇 |
2011年 | 46876篇 |
2010年 | 27065篇 |
2009年 | 24917篇 |
2008年 | 42707篇 |
2007年 | 45047篇 |
2006年 | 45159篇 |
2005年 | 43582篇 |
2004年 | 41541篇 |
2003年 | 39406篇 |
2002年 | 38213篇 |
2001年 | 60721篇 |
2000年 | 62347篇 |
1999年 | 51916篇 |
1998年 | 13683篇 |
1997年 | 12259篇 |
1996年 | 12158篇 |
1995年 | 12353篇 |
1994年 | 11567篇 |
1993年 | 10827篇 |
1992年 | 41479篇 |
1991年 | 40739篇 |
1990年 | 39422篇 |
1989年 | 37312篇 |
1988年 | 34540篇 |
1987年 | 33667篇 |
1986年 | 32118篇 |
1985年 | 30619篇 |
1984年 | 22990篇 |
1983年 | 19524篇 |
1982年 | 11690篇 |
1981年 | 10221篇 |
1979年 | 20759篇 |
1978年 | 14769篇 |
1977年 | 12014篇 |
1976年 | 11833篇 |
1975年 | 12081篇 |
1974年 | 14774篇 |
1973年 | 14452篇 |
1972年 | 13349篇 |
1971年 | 12408篇 |
1970年 | 11472篇 |
1969年 | 10402篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
J. Barnett I. Pulzato M. Javed Y.J. Lee A. Choraria S.V. Kemp A. Rice S. Jordan P.L. Shah A.G. Nicholson S. Padley A. Devaraj 《Clinical radiology》2021,76(1):77.e9-77.e15
45.
L.S. Becker S.K. Maschke C.L.A. Dewald T.C. Meine H.B.M. Winther M.M. Kirstein R. Kloeckner B.C. Meyer F. Wacker J.B. Hinrichs 《Clinical radiology》2021,76(2):160.e27-160.e33
46.
Nicolas Zhou Matthew Bott Bernard J. Park Eric Vallières Candice L. Wilshire Kazuhiro Yasufuku Jonathan D. Spicer David R. Jones Boris Sepesi 《The Journal of thoracic and cardiovascular surgery》2021,161(3):760-771.e2
BackgroundAdjuvant chemotherapy, postoperative radiation (PORT), and prophylactic cranial irradiation (PCI) have been individually examined in limited-stage small cell lung cancer (SCLC). There is a paucity of data on the effectiveness of each adjuvant treatment modality when used in combination after surgical resection of SCLC.MethodsData were collected from 5 cancer centers on all patients with limited-stage SCLC who underwent surgical resection between 1986 and 2019. Univariate and multivariable models were conducted to identify predictors of long-term outcomes, focusing on freedom from recurrence and survival benefit of adjuvant chemotherapy, PORT, and PCI.ResultsA total of 164 patients were analyzed. Multivariable Cox regression analysis did not identify any adjuvant therapies to significantly influence recurrence in this cohort. Specifically, PORT was not associated with a significant influence on locoregional recurrence and PCI was not significantly associated with intracranial outcomes. Adjuvant chemotherapy improved survival in all stage I through III disease (hazard ratio, 0.49; 95% confidence interval, 0.29-0.81; P = .005) and even in pathologically node negative patients (hazard ratio, 0.49; 95% confidence interval, 0.27-0.91; P = .024). Although PCI was found to improve survival in univariate analysis, it was not significant in a multivariable model. PORT was not found to affect survival on either univariate or multivariable analysis.ConclusionsThis is among the largest multi-institutional studies on surgically resected limited-stage SCLC. Our results highlight survival benefit of adjuvant chemotherapy, but did not identify a statistically significant influence from mediastinal PORT or PCI in our cohort. Larger prospective studies are needed to determine the benefit of PORT or PCI in a surgically resected limited-stage SCLC population. 相似文献
47.
48.
J. Ripollés-Melchor C. Aldecoa E. Alday-Muñoz S. del Río A. Batalla E. del-Cojo-Peces R. Uña-Orejón J.L. Muñoz-Rodés J.V. Lorente Á.V. Espinosa C. Ferrando-Ortolà J.L. Jover A. Abad-Gurumeta J.M. Ramírez-Rodríguez A. Abad-Motos 《Revista espa?ola de anestesiología y reanimación》2021,68(7):373-383
BackgroundThe optimal regimen for intravenous administration of intraoperative fluids remains unclear. Our goal was to analyze intraoperative crystalloid volume administration practices and their association with postoperative outcomes.MethodsWe extracted clinical data from two multicenter observational studies including adult patients undergoing colorectal surgery and total hip (THA) and knee arthroplasty (TKA). We analyzed the distribution of intraoperative fluid administration. Regression was performed using a general linear model to determine factors predictive of fluid administration. Patient outcomes and intraoperative crystalloid utilization were summarized for each surgical cohort. Regression models were developed to evaluate associations of high or low intraoperative crystalloid with the likelihood of increased postoperative complications, mainly acute kidney injury (AKI) and hospital length of stay (LOS).Results7,580 patients were included. The average adjusted intraoperative crystalloid infusion rate across all surgeries was to 7.9 (SD 4) mL/kg/h. The regression model strongly favored the type of surgery over other patient predictors. We found that high fluid volume was associated with 40% greater odds ratio (OR 1.40; 95% confidence interval1.01-1.95, p = 0.044) of postoperative complications in patients undergoing THA, while we found no associations for the other types of surgeries, AKI and LOSConclusionsA wide variability was observed in intraoperative crystalloid volume administration; however, this did not affect postoperative outcomes. 相似文献
49.
50.